Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

2 Sep 2025 07:00

RNS Number : 5366X
Synectics PLC
02 September 2025
 

 

2 September 2025

 

 

 

 

Synectics plc

("Synectics" or the "Company")

 

Director/PDMR Shareholding

 

Synectics plc (AIM: SNX), a leader in advanced security and surveillance solutions, announces that, on 1 September 2025, Amanda Larnder, Chief Executive Officer and an Executive Director of the Company, exercised options over 62,000 ordinary shares of 20 pence each in the Company ("Ordinary Shares") and David Aindow, Chief Strategy Officer for Synectic Systems and a PDMR of the Company, exercised options over 20,000 Ordinary Shares, in each case at a price of £3.15 per Ordinary Share ("Exercise Price"), which had vested under the performance criteria of the Company's Performance Share Plan ("PSP") and were granted on 1 August 2022 (the "Option Exercise").

 

In order to satisfy the tax liability due under each Option Exercise, the Company has implemented a net settlement arrangement. As such, 29,140 Ordinary Shares and 9,400 Ordinary Shares, respectively, were withheld from issue to Amanda Larnder and David Aindow at the Exercise Price, the value of which will be paid by the Company to His Majesty's Revenue and Customs by the Company on their behalf (the "Tax Liability").

 

Following the Option Exercise and net settlement of the Tax Liability, Amanda Larnder has been issued 32,860 Ordinary Shares and David Aindow has been issued 10,600 Ordinary Shares. In addition, on 1 September 2025, David Aindow, sold these 10,600 Ordinary Shares at a price of £3.150 per Ordinary Share.

 

The Ordinary Shares issued pursuant to the Option Exercise have been satisfied by way of a transfer of Ordinary Shares currently held by the Company's employee benefit trust. Further details of the PSP can be found in the Company's annual report and accounts at www.synecticsplc.com.

 

Summary of transactions:

 

Name

Position

Status

Number of options under the PSP exercised

Ordinary Shares issued (net of Tax Liability)

Number of Ordinary Shares sold

Amanda Larnder

Chief Executive Officer

Executive Director

62,000

32,860

0

David Aindow

Chief Strategy Officer, Synectic Systems

PDMR

20,000

10,600

10,600

 

Following these transactions, their interests in Ordinary Shares are as follows:

 

Name

Number of Ordinary Shares Held

% of Issued Share Capital

Remaining interest in Options over Ordinary Shares

Amanda Larnder

37,816

0.2

1,102,000

David Aindow

2,000

0.01

40,351

 

 

For further information, please contact:

 

Synectics plc

Claire Stewart, Company Secretary

email: info@synecticsplc.com

Tel: +44 (0) 114 280 2828

www.synecticsplc.com

 

 

Shore Capital

Tel: +44 (0) 20 7408 4090

Corporate Advisory: Tom Griffiths / David Coaten / George Payne

Corporate Broking: Fiona Conroy

 

Vigo Consulting  

Jeremy Garcia / Fiona Hetherington / Peter Jacob 

synectics@vigoconsulting.com  

Tel: +44 (0) 20 7390 0230

 

 

 

About Synectics plc

 

Synectics plc (AIM: SNX) is a leader in advanced security and surveillance solutions that help protect people, property and assets around the world.

 

It transforms customer operations by seamlessly integrating systems, technologies, and data into a unified solution-enhancing safety, improving efficiency, and enabling smarter, faster decision-making and response capabilities.

 

With its technical expertise, decades of experience, and strong partnerships, Synectics sets itself apart by delivering innovation and service that drive real value and long-term success.

 

Find out more at www.synecticsplc.com.

 

 

The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation, is appended below.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

1

Details of the person discharging managerial responsibilities / person closely associated (PCA)

a)

Name

 

Executive Director:

Amanda Larnder

Chief Executive Officer

 

PDMR:

David Aindow

Chief Strategy Officer

 

 

2

Reason for the notification

a)

Position/status

See 1a) above

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Synectics plc

 

 

b)

LEI

213800C1F7YZH96U2Z49

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 20 pence each

GB0007156838

b)

Nature of the transaction

Exercise of options under Performance Share Plan

 

c)

Price(s) and volume(s)

Price: £3.150

 

Volumes:

 

Amanda Larnder

62,000

David Aindow

20,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

e)

Date of the transaction

01 September 2025

 

 

f)

Place of the transaction

AIM, London Stock Exchange

 

 

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated (PCA)

a)

Name

 

PDMR:

David Aindow

Chief Strategy Officer

 

 

2

Reason for the notification

a)

Position/status

See 1a) above

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Synectics plc

 

 

b)

LEI

213800C1F7YZH96U2Z49

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 20 pence each

GB0007156838

b)

Nature of the transaction

Sale of Ordinary Shares

 

c)

Price(s) and volume(s)

Price: £3.150

 

Volumes:

 

David Aindow

10,600

 

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

e)

Date of the transaction

01 September 2025

 

 

f)

Place of the transaction

AIM, London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAKNFEAPSEFA
Date   Source Headline
8th Jun 20267:00 amRNSEBT Share Purchase
1st Jun 20261:48 pmRNSEBT Share Purchase
20th May 20267:00 amRNSFunding of EBT to Acquire Ordinary Shares and RPT
18th May 202612:48 pmRNSResult of AGM
18th May 20267:01 amRNSBoard Change
18th May 20267:00 amRNSAGM Trading Update
23rd Apr 20261:30 pmRNSCorrection to Notice of Annual General Meeting
14th Apr 20267:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
13th Mar 20262:05 pmRNSDirector dealings
12th Mar 20267:00 amRNSDirector Dealings
9th Mar 202610:20 amRNSDirector Dealings
3rd Mar 20263:30 pmRNSDirector / PCA Dealings
3rd Mar 20267:00 amRNSFinal Results and Strategic Update
24th Feb 202612:15 pmRNSNotice of Final Results and Investor Presentation
23rd Feb 20267:00 amRNSOngoing New Business Momentum
19th Feb 20261:41 pmRNSHolding(s) in Company
19th Jan 20269:00 amRNSHoldings in Company
18th Dec 202510:00 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSFull Year Trading Update
24th Nov 20257:00 amRNS-RExtension of Framework Agreement with Stagecoach
3rd Nov 20257:00 amRNS£1.8 million contract with Bus Eireann
16th Oct 20257:01 amRNSNew Contracts - Traction in Broader Energy Sector
16th Oct 20257:01 amRNSTrading Update
16th Oct 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
9th Oct 202512:16 pmRNSDirector dealings
2nd Oct 20257:00 amRNSPDMR dealings
2nd Sep 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSPDMR dealings
16th Jul 20257:00 amRNSLeisure & Hospitality Contract Wins
8th Jul 20257:00 amRNSHalf-year Report
19th Jun 20257:00 amRNSAppointment of Chief Financial Officer
9th Jun 20257:00 amRNSTrading Update and Notice of Results
4th Jun 20257:00 amRNSUS$4.8m Contract Extension
21st May 20257:00 amRNSPDMR Dealings
12th May 20257:00 amRNS£1.1 million Contract Award
7th May 20251:00 pmRNSResult of Annual General Meeting
7th May 20257:00 amRNSAGM Trading Update
2nd Apr 20257:00 amRNSPDMR dealings
1st Apr 20257:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
31st Mar 20257:00 amRNS£2.0 million Award
4th Mar 20257:00 amRNSFinal Results
14th Feb 20257:00 amRNSNotice of Final Results and Investor Presentation
27th Jan 20257:00 amRNS$2.2 million Contract Award
13th Jan 20255:30 pmRNSHoldings in Company
6th Jan 20258:40 amRNSHoldings in Company
6th Jan 20258:30 amRNSHoldings in Company
9th Dec 20241:30 pmRNSHoldings in Company
9th Dec 20247:00 amRNSTrading Update
5th Dec 20247:00 amRNS$2.7 million Contract Awards
27th Nov 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.